Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,770 | -220,030 | -155,349 | -103,410 | -61,559 |
| Depreciation Amortization | 1,639 | 5,899 | 4,688 | 3,184 | 1,595 |
| Accounts receivable | -13 | -1,561 | -317 | 0 | 0 |
| Other Working Capital | -9,407 | 31,985 | 6,519 | 8,129 | 2,329 |
| Other Operating Activity | 6,863 | 34,242 | 26,266 | 20,218 | 14,287 |
| Operating Cash Flow | $-60,688 | $-149,465 | $-118,193 | $-71,879 | $-43,348 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,000 | 23,938 | 92,222 | 49,019 | 44,750 |
| PPE Investments | -1,168 | -3,401 | -2,316 | -1,169 | -532 |
| Purchase Of Investment | N/A | -10,695 | -10,695 | N/A | N/A |
| Purchase Sale Intangibles | -410 | -1,432 | -982 | -640 | -391 |
| Other Investing Activity | -410 | -1,432 | -982 | -640 | -391 |
| Investing Cash Flow | $19,422 | $8,410 | $78,229 | $47,210 | $43,827 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 20,000 | 19,601 | 19,734 | N/A |
| Debt Repayment | -2,525 | -2,598 | -2,573 | -49 | -25 |
| Common Stock Issued | 1,488 | 130,805 | 5,204 | 971 | 431 |
| Other Financing Activity | 0 | -399 | 0 | 0 | 0 |
| Financing Cash Flow | $-1,037 | $147,808 | $22,232 | $20,656 | $406 |
| Beginning Cash Position | 80,439 | 73,687 | 73,551 | 73,551 | 73,551 |
| End Cash Position | 38,136 | 80,440 | 55,819 | 69,538 | 74,436 |
| Net Cash Flow | $-42,303 | $6,753 | $-17,732 | $-4,013 | $885 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,688 | -149,465 | -118,193 | -71,879 | -43,348 |
| Capital Expenditure | -1,168 | -3,401 | -2,316 | -1,169 | -532 |
| Free Cash Flow | -61,856 | -152,866 | -120,509 | -73,048 | -43,880 |